BUY TATA CONSUMER PRODUCTS LIMITED — Nuvama Wealth
byNuvama WealthHorizon: NA (inferred 1 year)27 Oct 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Tata Consumer Q2 Results: Net profit rises 16% YoY to Rs 470 crore, revenue up 14%
NewsEt-Markets·26 Oct · today
Tata Consumer Products Q2 profit rises 18%, revenue rises 14% to ₹5,661 crore
NewsCnbc-Tv18·26 Oct · today
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·27 Oct · today
15 other SEBI-registered advisors have active long-term BUY calls on this stock, with 6 issued in the last 14 days
Advisor consensus · same horizon·27 Oct · today
Tata Consumer Products Q2 Results: Net Profit, Revenue Beat Estimates; Margin Expands To 14%
NewsNdtv-Profit·26 Oct · yesterday
Tata consumer Q2 net profit up despite higher costs, weak tea demand
NewsEt-Markets·27 Oct · today
TATA CONSUMER PRODUCTS LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026.
NSE · Outcome of Board Meeting·26 Oct · yesterday
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·26 Oct · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on TATA CONSUMER PRODUCTS
- BUY — Kunal Bothra27 Oct 2026 · Same day · target ₹1,000 · Expired
- BUY — Citigroup27 Oct 2026 · ~1 year · target ₹1,225 · Active
- BUY — Ansh Jogendra Bhilwar27 Oct 2026 · ~3 months · target ₹1,020 · Active
- BUY — Jefferies India27 Oct 2026 · ~1 year · target ₹1,250 · Active
- BUY — Elara Capital27 Oct 2026 · ~1 year · target ₹1,080 · Active
More from Nuvama Wealth
- BUY Dr. Reddy's Laboratories26 Oct 2026 · ~1 year · target ₹1,415 · Active
- BUY SRF23 Oct 2026 · ~1 year · target ₹2,905 · Active
- BUY Colgate Palmolive (India)23 Oct 2026 · ~1 year · target ₹2,905 · Active
- BUY UltraTech Cement21 Oct 2026 · ~1 year · target ₹14,598 · Active
- BUY Hindustan Zinc21 Oct 2026 · ~1 year · target ₹676 · Active

